Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine hydrochloride injection vs morphine for postoperative analgesia
CTR20242099Phase 3Completed
- Sponsor
- Jiangsu Zilong Pharmaceutical
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in postoperative pain, None, labor pain, sponsored by Jiangsu Zilong Pharmaceutical. Started Jun 2024; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative painlabor pain
Beyond the preview
Go deeper on CTR20242099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242099.